151 related articles for article (PubMed ID: 23715437)
1. Inhibition of TORC1 signaling and increased lifespan: gained in translation?
Rallis C; Bähler J
Aging (Albany NY); 2013 May; 5(5):335-6. PubMed ID: 23715437
[No Abstract] [Full Text] [Related]
2. TORC1 signaling inhibition by rapamycin and caffeine affect lifespan, global gene expression, and cell proliferation of fission yeast.
Rallis C; Codlin S; Bähler J
Aging Cell; 2013 Aug; 12(4):563-73. PubMed ID: 23551936
[TBL] [Abstract][Full Text] [Related]
3. TOR-inhibitors as gero-suppressors.
Nikiforov M
Aging (Albany NY); 2015 Dec; 7(12):1030-1. PubMed ID: 26796970
[No Abstract] [Full Text] [Related]
4. Metabolic regulation, mitochondria and the life-prolonging effect of rapamycin: a mini-review.
Pan Y; Nishida Y; Wang M; Verdin E
Gerontology; 2012; 58(6):524-30. PubMed ID: 22947849
[TBL] [Abstract][Full Text] [Related]
5. TORC1 of fission yeast is rapamycin-sensitive.
Takahara T; Maeda T
Genes Cells; 2012 Aug; 17(8):698-708. PubMed ID: 22762302
[TBL] [Abstract][Full Text] [Related]
6. mTOR signaling for biological control and cancer.
Alayev A; Holz MK
J Cell Physiol; 2013 Aug; 228(8):1658-64. PubMed ID: 23460185
[TBL] [Abstract][Full Text] [Related]
7. The TORC1/P70S6K and TORC1/4EBP1 signaling pathways have a stronger contribution on skeletal muscle growth than MAPK/ERK in an early vertebrate: Differential involvement of the IGF system and atrogenes.
Fuentes EN; Einarsdottir IE; Paredes R; Hidalgo C; Valdes JA; Björnsson BT; Molina A
Gen Comp Endocrinol; 2015 Jan; 210():96-106. PubMed ID: 25449137
[TBL] [Abstract][Full Text] [Related]
8. Targeting mTOR Signaling Can Prevent the Progression of FSGS.
Zschiedrich S; Bork T; Liang W; Wanner N; Eulenbruch K; Munder S; Hartleben B; Kretz O; Gerber S; Simons M; Viau A; Burtin M; Wei C; Reiser J; Herbach N; Rastaldi MP; Cohen CD; Tharaux PL; Terzi F; Walz G; Gödel M; Huber TB
J Am Soc Nephrol; 2017 Jul; 28(7):2144-2157. PubMed ID: 28270414
[TBL] [Abstract][Full Text] [Related]
9. Effective targeting of colorectal cancer cells using TORC1/2 kinase inhibitors in vitro and in vivo.
Zhang J; Jiang W; Liu W; Wu JJ; Song L; Cheng JX; Yao M; Yang LP; Yao DF
Future Oncol; 2016 Feb; 12(4):515-24. PubMed ID: 26776341
[TBL] [Abstract][Full Text] [Related]
10. Mammalian target of rapamycin and tuberous sclerosis complex.
Wataya-Kaneda M
J Dermatol Sci; 2015 Aug; 79(2):93-100. PubMed ID: 26051878
[TBL] [Abstract][Full Text] [Related]
11. [mTORC1 and sirolimus: a link with fertility].
Tartarin P; Froment P
Med Sci (Paris); 2013 Feb; 29(2):200-5. PubMed ID: 23452608
[TBL] [Abstract][Full Text] [Related]
12. Disruption of alcohol-related memories by mTORC1 inhibition prevents relapse.
Barak S; Liu F; Ben Hamida S; Yowell QV; Neasta J; Kharazia V; Janak PH; Ron D
Nat Neurosci; 2013 Aug; 16(8):1111-7. PubMed ID: 23792945
[TBL] [Abstract][Full Text] [Related]
13. TORC2 Structure and Function.
Gaubitz C; Prouteau M; Kusmider B; Loewith R
Trends Biochem Sci; 2016 Jun; 41(6):532-545. PubMed ID: 27161823
[TBL] [Abstract][Full Text] [Related]
14. Five conditions commonly used to down-regulate tor complex 1 generate different physiological situations exhibiting distinct requirements and outcomes.
Tate JJ; Cooper TG
J Biol Chem; 2013 Sep; 288(38):27243-27262. PubMed ID: 23935103
[TBL] [Abstract][Full Text] [Related]
15. Isp7 is a novel regulator of amino acid uptake in the TOR signaling pathway.
Laor D; Cohen A; Pasmanik-Chor M; Oron-Karni V; Kupiec M; Weisman R
Mol Cell Biol; 2014 Mar; 34(5):794-806. PubMed ID: 24344203
[TBL] [Abstract][Full Text] [Related]
16. Potent dual inhibitors of TORC1 and TORC2 complexes (KU-0063794 and KU-0068650) demonstrate in vitro and ex vivo anti-keloid scar activity.
Syed F; Sanganee HJ; Singh S; Bahl A; Bayat A
J Invest Dermatol; 2013 May; 133(5):1340-50. PubMed ID: 23303455
[TBL] [Abstract][Full Text] [Related]
17. Medicine. A common pathway for a rare disease?
Vafai SB; Mootha VK
Science; 2013 Dec; 342(6165):1453-4. PubMed ID: 24357304
[No Abstract] [Full Text] [Related]
18. Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition.
de Cavanagh EM; Inserra F; Ferder L
Am J Physiol Heart Circ Physiol; 2015 Jul; 309(1):H15-44. PubMed ID: 25934099
[TBL] [Abstract][Full Text] [Related]
19. Drug synergy drives conserved pathways to increase fission yeast lifespan.
Huang X; Leggas M; Dickson RC
PLoS One; 2015; 10(3):e0121877. PubMed ID: 25786258
[TBL] [Abstract][Full Text] [Related]
20. Chemical probing of HER2-amplified cancer cells identifies TORC2 as a particularly effective secondary target for combination with lapatinib.
Amin DN; Ruiz-Saenz A; Gulizia N; Moasser MM
Oncotarget; 2015 Dec; 6(38):41123-33. PubMed ID: 26516700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
